{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:55:21Z","timestamp":1781070921363,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["PX2025055"],"award-info":[{"award-number":["PX2025055"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072243"],"award-info":[{"award-number":["82072243"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20220484169"],"award-info":[{"award-number":["20220484169"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2302903"],"award-info":[{"award-number":["2022YFC2302903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2302901"],"award-info":[{"award-number":["2022YFC2302901"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.intimp.2025.114831","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:03:18Z","timestamp":1747224198000},"page":"114831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pomalidomide promotes macrophage control of Mycobacterium tuberculosis via enhancing HDAC6-mediated autophagy"],"prefix":"10.1016","volume":"158","author":[{"given":"Fuzhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.114831_bb0005","series-title":"Global tuberculosis report 2023","author":"World Health Organization","year":"2023"},{"issue":"3","key":"10.1016\/j.intimp.2025.114831_bb0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/thoraxjnl-2017-211120","article-title":"Predicting tuberculosis relapse in patients treated with the standard 6-month regimen: an individual patient data meta-analysis","volume":"74","author":"Romanowski","year":"2019","journal-title":"Thorax"},{"issue":"17","key":"10.1016\/j.intimp.2025.114831_bb0015","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A four-month gatifloxacin-containing regimen for treating tuberculosis","volume":"371","author":"Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, Odhiambo J, Amukoye E, Bah B, Kassa F, N\u2019Diaye A, Rustomjee R, de Jong BC, Horton J, Perronne C, Sismanidis C, Lapujade O, Olliaro PL, Lienhardt C, Project OFGfT","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.intimp.2025.114831_bb0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.114831_bb0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/aje\/kwx380","article-title":"Resistance and susceptibility to mycobacterium tuberculosis infection and disease in tuberculosis households in Kampala","volume":"187","author":"Stein","year":"2018","journal-title":"Uganda. Am J Epidemiol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114831_bb0030","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100614R","article-title":"HDAC6 contributes to human resistance against mycobacterium tuberculosis infection via mediating innate immune responses","volume":"35","author":"Zhang","year":"2021","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.intimp.2025.114831_bb0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2014.02.019","article-title":"Divergent roles of histone deacetylase 6 (HDAC6) and histone deacetylase 11 (HDAC11) on the transcriptional regulation of IL10 in antigen presenting cells","volume":"60","author":"Cheng","year":"2014","journal-title":"Mol. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114831_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006799","article-title":"HDAC6 controls innate immune and autophagy responses to TLR-mediated signalling by the intracellular bacteria listeria monocytogenes","volume":"13","author":"Moreno-Gonzalo","year":"2017","journal-title":"PLoS Pathog."},{"issue":"29","key":"10.1016\/j.intimp.2025.114831_bb0045","doi-asserted-by":"crossref","first-page":"47890","DOI":"10.18632\/oncotarget.18141","article-title":"Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6","volume":"8","author":"Tan","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.intimp.2025.114831_bb0050","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1021\/acs.jmedchem.9b00516","article-title":"Development of multifunctional histone deacetylase 6 degraders with potent Antimyeloma activity","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2025.114831_bb0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/acsmedchemlett.0c00046","article-title":"Development of selective histone deacetylase 6 (HDAC6) degraders recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase","volume":"11","author":"Yang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2025.114831_bb0060","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1021\/acs.jmedchem.0c00161","article-title":"Structure-activity relationship of SPOP inhibitors against kidney Cancer","volume":"63","author":"Dong","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2025.114831_bb0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2016.08.003","article-title":"Small-molecule targeting of E3 ligase adaptor SPOP in kidney Cancer","volume":"30","author":"Guo","year":"2016","journal-title":"Cancer Cell"},{"issue":"7597","key":"10.1016\/j.intimp.2025.114831_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nature16979","article-title":"Structural basis of lenalidomide-induced CK1\u03b1 degradation by the CRL4(CRBN) ubiquitin ligase","volume":"532","author":"Petzold","year":"2016","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.intimp.2025.114831_bb0075","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1021\/jm5011258","article-title":"Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel-Lindau (VHL) E3 ubiquitin ligase and the hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities","volume":"57","author":"Galdeano","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.114831_bb0080","doi-asserted-by":"crossref","first-page":"13312","DOI":"10.1038\/ncomms13312","article-title":"Potent and selective chemical probe of hypoxic signalling downstream of HIF-\u03b1 hydroxylation via VHL inhibition","volume":"7","author":"Frost","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2025.114831_bb0085","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2147\/IDR.S240716","article-title":"Comparison of in vitro susceptibility of mycobacteria against PA-824 to identify key residues of Ddn, the Deazoflavin-dependent Nitroreductase from mycobacterium tuberculosis","volume":"13","author":"Zhang","year":"2020","journal-title":"Infect Drug Resist."},{"issue":"2","key":"10.1016\/j.intimp.2025.114831_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021772","article-title":"Role of NF-\u03baB during mycobacterium tuberculosis infection","volume":"24","author":"Poladian","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.114831_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0965-1748(98)00025-3","article-title":"Characterization of ATPases of apical membrane fractions from Locusta migratoria Malpighian tubules","volume":"28","author":"Al-Fifi","year":"1998","journal-title":"Insect Biochem. Mol. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2025.114831_bb0100","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41423-020-0502-z","article-title":"New insights into the evasion of host innate immunity by mycobacterium tuberculosis","volume":"17","author":"Chai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"46","key":"10.1016\/j.intimp.2025.114831_bb0105","doi-asserted-by":"crossref","first-page":"35759","DOI":"10.1074\/jbc.M110.126904","article-title":"Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6","volume":"285","author":"Into","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.intimp.2025.114831_bb0110","doi-asserted-by":"crossref","first-page":"6975","DOI":"10.1158\/0008-5472.CAN-16-0504","article-title":"TLR adaptor protein MYD88 mediates sensitivity to HDAC inhibitors via a cytokine-dependent mechanism","volume":"76","author":"New","year":"2016","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114831_bb0115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/emboj.2009.405","article-title":"HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy","volume":"29","author":"Lee","year":"2010","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.intimp.2025.114831_bb0120","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00018-019-03353-5","article-title":"Host defense mechanisms against mycobacterium tuberculosis","volume":"77","author":"Chai","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2025.114831_bb0125","first-page":"231","article-title":"MxA suppresses TAK1-IKK\u03b1\/\u03b2-NF-\u03baB mediated inflammatory cytokine production to facilitate mycobacterium tuberculosis infection","volume":"81","author":"Zhou","year":"2020","journal-title":"J. Inf. Secur."},{"issue":"24","key":"10.1016\/j.intimp.2025.114831_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246275","article-title":"NF-\u03baB signaling regulates physiological and pathological Chondrogenesis","volume":"20","author":"Jimi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.intimp.2025.114831_bb0135","doi-asserted-by":"crossref","first-page":"15292","DOI":"10.18632\/oncotarget.24577","article-title":"Pomalidomide promotes chemosensitization of pancreatic cancer by inhibition of NF-\u03baB","volume":"9","author":"Shirai","year":"2018","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.intimp.2025.114831_bb0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3109\/10428194.2012.728597","article-title":"Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma","volume":"54","author":"Zhu","year":"2013","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.intimp.2025.114831_bb0145","doi-asserted-by":"crossref","first-page":"2327096","DOI":"10.1080\/21505594.2024.2327096","article-title":"The role of HDAC6 in enhancing macrophage autophagy via the autophagolysosomal pathway to alleviate legionella pneumophila-induced pneumonia","volume":"15","author":"Chen","year":"2024","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.intimp.2025.114831_bb0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/dna.2014.2745","article-title":"Autophagy in the fight against tuberculosis","volume":"34","author":"Bento","year":"2015","journal-title":"DNA Cell Biol."},{"issue":"11","key":"10.1016\/j.intimp.2025.114831_bb0155","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.intimp.2025.114831_bb0160","doi-asserted-by":"crossref","unstructured":"Corral LG, Haslett PAJ, Muller GW, Chen R, Wong LM, Ocampo CJ, Patterson RT, Stirling DI, Kaplan G. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-\u03b1. J. Immunol. 1999;163(1):380\u20136.DOI.","DOI":"10.4049\/jimmunol.163.1.380"},{"issue":"17","key":"10.1016\/j.intimp.2025.114831_bb0165","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1182\/blood-2010-04-279893","article-title":"Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma","volume":"116","author":"Gorgun","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.114831_bb0170","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/leu.2015.240","article-title":"SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide","volume":"30","author":"Jiang","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.intimp.2025.114831_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2013.38","article-title":"Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma","volume":"3","author":"Chanan-Khan","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.intimp.2025.114831_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127393","article-title":"Immune checkpoint modulating T cells and NK cells response to mycobacterium tuberculosis infection","volume":"273","author":"Qin","year":"2023","journal-title":"Microbiol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114831_bb0185","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/ejh.13039","article-title":"Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma","volume":"100","author":"Gueneau","year":"2018","journal-title":"Eur. J. Haematol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925008215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:49:03Z","timestamp":1762552143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925008215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":37,"alternative-id":["S1567576925008215"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114831","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pomalidomide promotes macrophage control of Mycobacterium tuberculosis via enhancing HDAC6-mediated autophagy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114831"}}